+Search query
-Structure paper
Title | Development and structural basis of a two-MAb cocktail for treating SARS-CoV-2 infections. |
---|---|
Journal, issue, pages | Nat Commun, Vol. 12, Issue 1, Page 264, Year 2021 |
Publish date | Jan 11, 2021 |
Authors | Chao Zhang / Yifan Wang / Yuanfei Zhu / Caixuan Liu / Chenjian Gu / Shiqi Xu / Yalei Wang / Yu Zhou / Yanxing Wang / Wenyu Han / Xiaoyu Hong / Yong Yang / Xueyang Zhang / Tingfeng Wang / Cong Xu / Qin Hong / Shutian Wang / Qiaoyu Zhao / Weihua Qiao / Jinkai Zang / Liangliang Kong / Fangfang Wang / Haikun Wang / Di Qu / Dimitri Lavillette / Hong Tang / Qiang Deng / Youhua Xie / Yao Cong / Zhong Huang / |
PubMed Abstract | The ongoing pandemic of coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Neutralizing antibodies against SARS-CoV-2 are an option for ...The ongoing pandemic of coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Neutralizing antibodies against SARS-CoV-2 are an option for drug development for treating COVID-19. Here, we report the identification and characterization of two groups of mouse neutralizing monoclonal antibodies (MAbs) targeting the receptor-binding domain (RBD) on the SARS-CoV-2 spike (S) protein. MAbs 2H2 and 3C1, representing the two antibody groups, respectively, bind distinct epitopes and are compatible in formulating a noncompeting antibody cocktail. A humanized version of the 2H2/3C1 cocktail is found to potently neutralize authentic SARS-CoV-2 infection in vitro with half inhibitory concentration (IC50) of 12 ng/mL and effectively treat SARS-CoV-2-infected mice even when administered at as late as 24 h post-infection. We determine an ensemble of cryo-EM structures of 2H2 or 3C1 Fab in complex with the S trimer up to 3.8 Å resolution, revealing the conformational space of the antigen-antibody complexes and MAb-triggered stepwise allosteric rearrangements of the S trimer, delineating a previously uncharacterized dynamic process of coordinated binding of neutralizing antibodies to the trimeric S protein. Our findings provide important information for the development of MAb-based drugs for preventing and treating SARS-CoV-2 infections. |
External links | Nat Commun / PubMed:33431876 / PubMed Central |
Methods | EM (single particle) |
Resolution | 3.0 - 13.5 Å |
Structure data | EMDB-30635, PDB-7dcc: EMDB-30641, PDB-7dcx: EMDB-30642, PDB-7dd2: EMDB-30649, PDB-7dd8: EMDB-30651, PDB-7ddd: EMDB-30654, PDB-7ddn: EMDB-30702, PDB-7dk4: EMDB-30703, PDB-7dk5: EMDB-30704, PDB-7dk6: EMDB-30705, PDB-7dk7: |
Source |
|
Keywords | VIRAL PROTEIN / SARS-Cov2 S protein |